US Penny Stocks To Watch In January 2025

As of mid-January 2025, U.S. markets have experienced a slight decline as investors process a wave of earnings reports, with major tech stocks like Tesla and Apple leading the downturn. For those interested in exploring smaller or newer companies, penny stocks—despite their somewhat outdated name—remain an intriguing investment option. These stocks can offer affordability and growth potential when backed by strong financials, making them worth considering for investors seeking opportunities beyond the mainstream market.

Top 10 Penny Stocks In The United States

Name	Share Price	Market Cap	Financial Health Rating
QuantaSing Group (NasdaqGM:QSG)	$3.08	$91.49M	★★★★★★
BAB (OTCPK:BABB)	$0.884275	$6.54M	★★★★★★
Kiora Pharmaceuticals (NasdaqCM:KPRX)	$3.50	$10.2M	★★★★★★
Inter & Co (NasdaqGS:INTR)	$4.65	$2B	★★★★☆☆
ZTEST Electronics (OTCPK:ZTST.F)	$0.285	$11.23M	★★★★★★
Golden Growers Cooperative (OTCPK:GGRO.U)	$4.50	$67.38M	★★★★★★
BTCS (NasdaqCM:BTCS)	$2.68	$48.23M	★★★★★★
Smith Micro Software (NasdaqCM:SMSI)	$1.13	$20.22M	★★★★★☆
CBAK Energy Technology (NasdaqCM:CBAT)	$0.908	$82.23M	★★★★★☆
Safe Bulkers (NYSE:SB)	$3.41	$380.13M	★★★★☆☆

Click here to see the full list of 712 stocks from our US Penny Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

Freightos (NasdaqCM:CRGO)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Freightos Limited operates a vendor-neutral booking and payment platform for international freight, with a market cap of $162.88 million.

Operations: Freightos Limited has not reported any specific revenue segments.

Market Cap: $162.88M

Freightos Limited, with a market cap of US$162.88 million, has shown promising revenue growth despite being unprofitable. Recent earnings guidance for Q4 2024 indicates revenue between US$6.4 million and US$6.5 million, reflecting a year-over-year increase of 21% to 24%. The company reported sales of US$6.19 million in Q3 2024, up from US$5.11 million the previous year, while net losses decreased significantly to US$2.72 million from US$7.16 million year-on-year. Freightos remains debt-free and maintains a strong cash runway exceeding three years, supported by strategic partnerships like its integration with e2open's TMS application for enhanced air cargo booking efficiency.

• Dive into the specifics of Freightos here with our thorough balance sheet health report.
• Review our growth performance report to gain insights into Freightos' future.

Chimerix (NasdaqGM:CMRX)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Chimerix, Inc. is a biopharmaceutical company focused on developing medicines to improve and extend the lives of patients with deadly diseases, with a market cap of $312.08 million.

Operations: The company's revenue segment is derived entirely from its Pharmaceuticals business, totaling $0.159 million.

Market Cap: $312.08M

Chimerix, Inc., with a market cap of US$312.08 million, is pre-revenue and focuses on developing treatments for life-threatening diseases. Despite being unprofitable, the company has managed to reduce losses by 20.7% annually over the past five years and maintains a stable cash runway exceeding one year. Recent developments include submitting a New Drug Application to the FDA for dordaviprone, aiming for accelerated approval with potential priority review status. Chimerix remains debt-free but recently secured a US$30 million credit facility from Silicon Valley Bank, providing financial flexibility without immediate borrowing obligations.

• Take a closer look at Chimerix's potential here in our financial health report.
• Evaluate Chimerix's prospects by accessing our earnings growth report.

Healthier Choices Management (OTCPK:HCMC)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Healthier Choices Management Corp. operates natural and organic retail stores in the United States with a market cap of $481,266.

Operations: The company generates revenue from its vapor segment, which amounts to $0.000923 million.

Market Cap: $481.27k

Healthier Choices Management Corp., with a market cap of US$481,266, is pre-revenue and faces significant financial challenges. The company reported minimal sales of US$0.000052 million for the third quarter of 2024, alongside a net loss of US$4.35 million, up from the previous year's loss. Despite having more cash than total debt and short-term assets exceeding liabilities, HCMC's debt-to-equity ratio has worsened over five years. The management team is experienced with an average tenure of 9.4 years but operates under high share price volatility and declining earnings over the past five years at a rate of 45.6% annually.

• Navigate through the intricacies of Healthier Choices Management with our comprehensive balance sheet health report here.
• Gain insights into Healthier Choices Management's historical outcomes by reviewing our past performance report.

Where To Now?

• Jump into our full catalog of 712 US Penny Stocks here.
• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
• Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.

Interested In Other Possibilities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com